Medion Biotech is proud to have an expanding global footprint, currently represented through our subsidiaries and strategic sales partners in over countries. We actively seek to collaborate with new export partners across neighboring and emerging markets to further our mission of delivering high-quality, affordable oncology medicines worldwide.

To support our global vision, we have established a dedicated export regulatory team focused on ensuring full compliance with international standards. This team manages all aspects of regulatory documentation and supports international audits, including the preparation of COPPs and Dossiers in CTD/ACTD formats, in alignment with stringent cGMP norms.

With a structured, compliance-driven approach, Medion Biotech is well-positioned to meet the evolving demands of global healthcare markets.